D Tomsitz1, K Brockow2. 1. Department of Dermatology and Allergy Biederstein, Technische Universität München, Biedersteiner Straße 29, 80802, Munich, Germany. 2. Department of Dermatology and Allergy Biederstein, Technische Universität München, Biedersteiner Straße 29, 80802, Munich, Germany. knut.brockow@tum.de.
Abstract
PURPOSE OF REVIEW: Hymenoptera anaphylaxis is one of the leading causes of severe allergic reactions and can be fatal. Venom-specific immunotherapy (VIT) can prevent a life-threatening reaction; however, confirmation of an allergy to a Hymenoptera venom is a prerequisite before starting such a treatment. Component resolved diagnostics (CRD) have helped to better identify the responsible allergen. RECENT FINDINGS: Many new insect venom allergens have been identified within the last few years. Commercially available recombinant allergens offer new diagnostic tools for detecting sensitivity to insect venoms. Additional added sensitivity to nearly 95% was introduced by spiking yellow jacket venom (YJV) extract with Ves v 5. The further value of CRD for sensitivity in YJV and honey bee venom (HBV) allergy is more controversially discussed. Recombinant allergens devoid of cross-reactive carbohydrate determinants often help to identify the culprit venom in patients with double sensitivity to YJV and HBV. CRD identified a group of patients with predominant Api m 10 sensitization, which may be less well protected by VIT, as some treatment extracts are lacking this allergen. The diagnostic gap of previously undetected Hymenoptera allergy has been decreased via production of recombinant allergens. Knowledge of analogies in interspecies proteins and cross-reactive carbohydrate determinants is necessary to distinguish relevant from irrelevant sensitizations.
PURPOSE OF REVIEW: Hymenoptera anaphylaxis is one of the leading causes of severe allergic reactions and can be fatal. Venom-specific immunotherapy (VIT) can prevent a life-threatening reaction; however, confirmation of an allergy to a Hymenoptera venom is a prerequisite before starting such a treatment. Component resolved diagnostics (CRD) have helped to better identify the responsible allergen. RECENT FINDINGS: Many new insect venom allergens have been identified within the last few years. Commercially available recombinant allergens offer new diagnostic tools for detecting sensitivity to insect venoms. Additional added sensitivity to nearly 95% was introduced by spiking yellow jacket venom (YJV) extract with Ves v 5. The further value of CRD for sensitivity in YJV and honey bee venom (HBV) allergy is more controversially discussed. Recombinant allergens devoid of cross-reactive carbohydrate determinants often help to identify the culprit venom in patients with double sensitivity to YJV and HBV. CRD identified a group of patients with predominant Api m 10 sensitization, which may be less well protected by VIT, as some treatment extracts are lacking this allergen. The diagnostic gap of previously undetected Hymenoptera allergy has been decreased via production of recombinant allergens. Knowledge of analogies in interspecies proteins and cross-reactive carbohydrate determinants is necessary to distinguish relevant from irrelevant sensitizations.
Authors: A Siracusa; I Folletti; R Gerth van Wijk; M F Jeebhay; G Moscato; S Quirce; M Raulf; F Ruëff; J Walusiak-Skorupa; P Whitaker; S M Tarlo Journal: Allergy Date: 2015-02 Impact factor: 13.146
Authors: M Worm; A Moneret-Vautrin; K Scherer; R Lang; M Fernandez-Rivas; V Cardona; M L Kowalski; M Jutel; I Poziomkowska-Gesicka; N G Papadopoulos; K Beyer; T Mustakov; G Christoff; M B Bilò; A Muraro; J O B Hourihane; L B Grabenhenrich Journal: Allergy Date: 2014-08-16 Impact factor: 13.146
Authors: Troy W Baker; Joseph P Forester; Monica L Johnson; Adrienne Stolfi; Mark C Stahl Journal: Ann Allergy Asthma Immunol Date: 2014-06-23 Impact factor: 6.347
Authors: J Michel; K Brockow; U Darsow; J Ring; C B Schmidt-Weber; T Grunwald; S Blank; M Ollert Journal: Allergy Date: 2016-02-23 Impact factor: 13.146
Authors: Peshala Gunasekara; S M Handunnetti; Sunil Premawansa; E W R A Witharana; Indra P Ratnayake; Pradeep Kaluarachchi; Chandima Karunatilake; R K S Dias; G A S Premakumara; W M D K Dasanayake; Suranjith L Seneviratne; Rajiva de Silva Journal: Clin Mol Allergy Date: 2022-09-14
Authors: Aida Abd El-Wahed; Nermeen Yosri; Hanem H Sakr; Ming Du; Ahmed F M Algethami; Chao Zhao; Ahmed H Abdelazeem; Haroon Elrasheid Tahir; Saad H D Masry; Mohamed M Abdel-Daim; Syed Ghulam Musharraf; Islam El-Garawani; Guoyin Kai; Yahya Al Naggar; Shaden A M Khalifa; Hesham R El-Seedi Journal: Toxins (Basel) Date: 2021-03-12 Impact factor: 4.546